Literature DB >> 29493079

Validating kQ =1.0 assumption in TG51 with PTW 30013 farmer chamber for Varian TrueBeam's 2.5 MV imaging beam.

Shelby Grzetic1,2, Ahmet S Ayan1, Jeffrey Woollard1, Nilendu Gupta1.   

Abstract

AAPM Report 142 recommends and the State of Ohio requires that the imaging dose be quantified in radiotherapy applications. Using the TG51 dose calibration protocol for MV Imaging dose measurement requires knowledge of the kQ parameter for the beam quality and the ionization chamber type under investigation. The %dd(10)x of the Varian TrueBeam 2.5 MV imaging beam falls outside the range of the available data for the calculation of the kQ value. Due to the similarities of the 2.5 MV imaging beam and the 60 Co beam, we and others made the assumption that kQ = 1.0 in TG51 calculations. In this study, we used the TG21 and TG51 calibration protocols in conjunction to validate that kQ = 1.0 for the 2.5 MV imaging beam using a PTW 30013 farmer chamber. Standard measurements for TG51 absolute dosimetry QA were performed at 100 cm SSD, 10 cm depth, 10 × 10 field size, delivering 100 Monitor Units to a waterproof Farmer Chamber (PTW TN30013) for both 2.5 and 6 MV. Both the TG21 and TG51 formalisms were used to calculate the dose to water per MU at dmax (Dw /MU) for the 6 MV beam. The calculated outputs were 1.0005 and 1.0004 cGy/MU respectively. The TG21 formalism was then used to calculate (Dw /MU) for the 2.5 MV imaging beam. This value was then used in the TG51 formalism to find kQ for the 2.5 MV imaging beam. A kQ value of 1.00 ± 0.01 was calculated for 2.5 MV using this method.
© 2018 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.

Entities:  

Keywords:  2.5 MV imaging dose; dose calibration

Mesh:

Year:  2018        PMID: 29493079      PMCID: PMC5978706          DOI: 10.1002/acm2.12290

Source DB:  PubMed          Journal:  J Appl Clin Med Phys        ISSN: 1526-9914            Impact factor:   2.102


INTRODUCTION

AAPM Report 1421 recommends and the Ohio Department of Health (ODH) requires that all imaging dose be quantified for imaging when performed on patients during image guided radiation therapy (IGRT).2 The diagnostic (kV) beams have well‐established protocols to measure the doses to patients when they are used for imaging. Similarly, MV range treatment beams also have well‐established dose calculation protocols such as AAPM's Task Group‐513 and the older Task Group‐21 protocols.4 These two protocols provide methodologies to calculate the dose to water for MV and 60Co beams. The absorbed‐dose‐to‐water factor, , based on the TG51 protocol uses a kQ factor which converts the calibration factor for a 60Co beam quality, for which the absorbed‐dose calibration factor is applicable, to a clinical beam quality of Q. In the TG51 protocol, kQ values are provided in a figure and also tabulated for a variety of cylindrical chambers and beam qualities which are defined as the %dd(10)x. The later published Addendum to TG515 provides an empirical formula to calculate the kQ for clinical beams of quality with %dd(10)x in the range of 63% to 86% and also provides kQ values for some newer ionization chambers such as PTW TN30013 (PTW GmbH, Freiburg, Germany). At our institution, we have Varian TrueBeam linear accelerators with 2.5 MV imaging beams. In an effort to meet the requirement of the ODH and to be able to characterize the dose given to patients during imaging with this beam, we set out to perform the dose quantification of the 2.5 MV imaging beam. In order to have an accurate output measurement, kQ must be known when using the TG51 formalism. We initially performed the calibration of this beam using the TG51 protocol with an assumed kQ value of 1.0. A recently published paper by Gräfe et al.6 showed a similar calibration again with the assumed kQ of 1.0, using the 2.5 MV imaging beam and 0.64 cc Exradin A12 (Standard Imaging Inc., Middleton, WI, USA) ionization chamber. In order to validate our assumption of kQ = 1.0 for the 2.5 MV imaging beam under consideration with the PTW TN30013 ionization chamber, we performed the calibration of the 2.5 MV with the older TG21 formalism, which does not require any knowledge of kQ. The aim of this study is to use the TG21 protocol for the absolute dosimetry calculation for the 2.5 MV beam to validate the assumed value for kQ to be used in a TG51 protocol absolute dosimetry calibration. Two previous studies have compared the doses calculated by the TG21 and TG51 protocols for megavoltage beam dosimetry. Cho et al.7 showed that for PTW N30001 & 23333 ion chambers, the TG51 to TG21 calculated dose ratio was 1.012 and 1.010 for 60Co and 6 MV photon beams respectively. Tailor et al.8 calculated the doses using both protocols for a variety of cylindrical chambers and photon beam energies. They showed that for the cylindrical chambers they tested the dose ratios were within ±1.0%, the highest being at the 60Co beam energy and decreasing with increasing photon energy.

MATERIALS AND METHODS

We measured the percentage depth dose (PDD) of the 2.5 MV imaging beam of a Varian TrueBeam linear accelerator with a CC13 (IBA Dosimetry, Schwarzenbruck, Germany) detector in a cylindrical 3D Scanner water tank (Sun Nuclear Corporation, Melbourne, FL, USA) for a 10 × 10 cm field size at 100 cm SSD. Our measured %dd(10)x for 2.5 MV is 51.53%. This is shown in Fig. 1. This value is outside the range of %dd(10)x as shown in fig. 4 of the TG51 report or the empirical formula valid range as given in eq. (1) in the TG51 addendum. Measurements were then taken at 10 cm depth, 100 cm SSD, 10 × 10 cm2 field size with a PTW waterproof farmer chamber (TN30013) to calculate Pion. The exposure calibration factor, Nx, and cavity‐gas factor, Ngas, were taken from the ADCL calibration certificate of the ionization chamber used and were verified against a calculated value of Ngas, using eq. (6) in TG21, assuming a PMMA (acrylic) wall and acrylic cap. Pwall was calculated using the mass stopping power ratio, L/ρ, and mean mass energy absorption coefficient, μen/ρ, listed in the TG21 formalism for the wall material, acrylic, based on specifications from the manufacturer (74% PMMA, 26% graphite).9
Figure 1

Measured PDD for the 2.5 MV imaging beam after shifting to the effective point of measurement.

Measured PDD for the 2.5 MV imaging beam after shifting to the effective point of measurement. In TG21 protocol, the dose to water is given bywhere And The fraction of ionization due to electrons from the chamber wall, α, was taken as zero using Fig. 1 of the TG21 protocol based on the nominal accelerating potential of 2.5 MV and the manufacturer‐specified chamber wall thickness of 0.056 g/cm2. Prepl was taken as 0.992 by using fig. 5 of the TG21 protocol. The factors and parameter values used in the TG21 calibration are listed in Tables 1 and 2. The first column of Tables 1 and 2 lists the corresponding item number in worksheet 1 and 2, respectively, in the TG21 protocol.
Table 1

Calculation of Ngas using both TG21 (Worksheet 1) and ADCL chamber calibration report

1.Chamber ModelPTW TN30013
Chamber wall thickness (g/cm2)0.056
Polarizing potential+300V
2.Nx (R/C)5.64E+09
3.k (C/kg R)2.58E‐04
W/e (J/C)33.7
βwall 1.005
4.Aion 1.000
Awall 0.990
Α0
(L¯/ρ)airwall 1.103
(μ¯/ρ)wallair 0.928
1‐α1
(L¯/ρ)aircap 1.103
(μ¯/ρ)capair 0.925
5.Ngas calculated from TG21 (Gy/C)4.779E+07
Ngas calculated from Calibration Certificate (Gy/C)4.780E+07
% Difference in Ngas 0.01%
Table 2

Calculation of dose to water per MU at dmax (cGy/MU) according to TG21

1.Nominal accelerating potential2.5 MV2.5 6 MV
2.Phantom MaterialWaterWater
SSD100 cm100 cm
Collimator Field Size (cm)10 × 1010 × 10
Depth (cm)1010
3.2Temperature (C)22.522.5
Pressure (mmHg)739.3739.3
PTP 1.02971.0297
3.3Raw Uncorrected Reading (C)9.17E‐091.21E‐08
Reading (C) corrected by PTP 9.44E‐111.24E‐10
3.4Chamber ModelFarmerFarmer
Wall MaterialPMMA + GraphitePMMA + Graphite
Inner Diameter (mm)6.16.1
Ngas (Gy/C)4.78E + 074.78E + 07
3.5 (L¯/ρ)airmed (fig. 2, table IV)1.1351.127
3.6Pwall (eq. 10)1.0021.000
a (fig. 7)0.450.25
(1‐α)0.550.75
(L¯/ρ)airwall (fig. 2, table IV)1.07991.0706
(μen¯/ρ)airmed (table IX)1.1111.11
(μen¯/ρ)airwall (table IX)1.05221.052
(μen¯/ρ)wallmed 1.0561.055
4.Pion (From TG51)1.0021.002
5.PRepl (fig. 5)0.9920.993
6.Dmed/MU (eq. 9) – Gy/MU0.00510.00667
7.2ESC (table XIV)1.0001.000
7.3 (μen¯/ρ)medwater (table XII)1.0001.000
7.4PDD at depth of measurement (%)0.51530.6659
7.5Dwater/MU (at dmax) – Gy/MU (eq. 17)0.0098960.0100
Dwater/MU (at dmax) – cGy/MU0.98961.0010
Calculation of Ngas using both TG21 (Worksheet 1) and ADCL chamber calibration report Calculation of dose to water per MU at dmax (cGy/MU) according to TG21 We calculated Ngas by using eq. (3) given above and also fromwhich is provided on the ADCL calibration certificate and the manufacturer specification sheet [8]. The calculated values of Ngas are shown in Table 1. After calculating (DW/MU)TG21 at the calibration dosimetry conditions using the TG21 protocol, we equated the calculated value to the TG51 equation used to calculate (DW/MU) for the same reference geometry and solved for kQ as shown in eqs. (5) and (6): Numeral values for this calculation are shown in Table 3. As a validation of the method, the same process was applied for the 6 MV beam.
Table 3

Calculation of dose to water per MU at dmax according to TG51 in addition to derivation of TG21 calculated kQ value

Measurements from TG512.5 MV6 MV
Mraw (C)9.17E‐091.21E‐08
PTP 1.02971.0297
PION 1.0021.00222
Pelec 1.0021.002
Ppol 1.0000.99959
ND,W 60Co 5.38E + 075.38E + 07
Clinical %dd(10)x 0.51530.6659
MU delivered100100
TG21 calculated kQ 1.00020.993
TG51 addendum – calculated kQ 1.0000.9919
% Difference0.02%0.06%
Calculation of dose to water per MU at dmax according to TG51 in addition to derivation of TG21 calculated kQ value

RESULTS

We calculated the absorbed dose ratio at the reference conditions as (TG51/TG21)Dose = 0.9994 for the 6 MV beam using the PTW 300013 ion chamber. Tailor et al.8 showed that (TG51/TG21)Dose = 1.003 for a 6 MV beam using PTW N30006 ion chamber. The N30006 is equivalent to PTW 30013 according to the manufacturer's specifications.9 Our result differs from Tailor et al.'s prediction by only 0.3%. Hence, we hypothesize that our PTW N30013 chamber material dependent TG21 protocol parameters (L/ρ) and (μen/ρ) are accurate. Next, by calculating the absorbed dose of the 2.5 MV imaging beam with the TG21 formalism and solving eq. (6), kQ value was calculated as 1.0002 (Table 3).

CONCLUSION

The method outlined yielded a kQ value of 1.0002 for the 2.5 MV TrueBeam imaging photon beam using the PTW TN30013 ionization chamber. This value is within 0.02% of our and Gräfe et al.'s assumed kQ = 1.0. With up to ±1% difference shown8 between the dose calibration for photon beams by using TG21 and TG51 protocols for 60Co to 18 MV photon energies, we assigned a 1% uncertainty in our calculation of kQ. The use of a kQ = 1.000 is adequate for the 2.5 MV imaging photon beam using the PTW TN30013 ionization chamber to characterize the imaging beam dose.

CONFLICT OF INTEREST

The authors have no conflicts of interest relevant to the content of this article.
  7 in total

1.  AAPM's TG-51 protocol for clinical reference dosimetry of high-energy photon and electron beams.

Authors:  P R Almond; P J Biggs; B M Coursey; W F Hanson; M S Huq; R Nath; D W Rogers
Journal:  Med Phys       Date:  1999-09       Impact factor: 4.071

2.  Calculated absorbed-dose ratios, TG51/TG21, for most widely used cylindrical and parallel-plate ion chambers over a range of photon and electron energies.

Authors:  R C Tailor; W F Hanson
Journal:  Med Phys       Date:  2002-07       Impact factor: 4.071

3.  Task Group 142 report: quality assurance of medical accelerators.

Authors:  Eric E Klein; Joseph Hanley; John Bayouth; Fang-Fang Yin; William Simon; Sean Dresser; Christopher Serago; Francisco Aguirre; Lijun Ma; Bijan Arjomandy; Chihray Liu; Carlos Sandin; Todd Holmes
Journal:  Med Phys       Date:  2009-09       Impact factor: 4.071

4.  Addendum to the AAPM's TG-51 protocol for clinical reference dosimetry of high-energy photon beams.

Authors:  Malcolm McEwen; Larry DeWerd; Geoffrey Ibbott; David Followill; David W O Rogers; Stephen Seltzer; Jan Seuntjens
Journal:  Med Phys       Date:  2014-04       Impact factor: 4.071

5.  A protocol for the determination of absorbed dose from high-energy photon and electron beams.

Authors: 
Journal:  Med Phys       Date:  1983 Nov-Dec       Impact factor: 4.071

6.  Comparison between TG-51 and TG-21: Calibration of photon and electron beams in water using cylindrical chambers.

Authors:  S H Cho; J R Lowenstein; P A Balter; N H Wells; W F Hanson
Journal:  J Appl Clin Med Phys       Date:  2000       Impact factor: 2.102

7.  Characterization of a 2.5 MV inline portal imaging beam.

Authors:  James L Gräfe; Jennifer Owen; J Eduardo Villarreal-Barajas; Rao F H Khan
Journal:  J Appl Clin Med Phys       Date:  2016-09-08       Impact factor: 2.102

  7 in total
  1 in total

1.  Calculating dose from a 2.5 MV imaging beam using a commercial treatment planning system.

Authors:  William S Ferris; Wesley S Culberson; Daniel R Anderson; Zacariah E Labby
Journal:  J Appl Clin Med Phys       Date:  2019-11-01       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.